Nuwellis is a medical devices business based in the US. Nuwellis shares (NUWE) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $1.48 – an increase of 22.78% over the previous week. Nuwellis employs 59 staff and has a trailing 12-month revenue of around $9 million.
Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
| Latest market close | $1.48 |
|---|---|
| 52-week range | $1.00 - $49.18 |
| 50-day moving average | $1.88 |
| 200-day moving average | $10.17 |
| Wall St. target price | $16.00 |
| PE ratio | N/A |
| Dividend yield | N/A |
| Earnings per share (TTM) | $-120.96 |
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $1.48 from 2024-10-03
| 1 week (2024-09-27) | 22.78% |
|---|---|
| 1 month (2024-09-04) | 40.95% |
| 3 months (2024-07-03) | -64.08% |
| 6 months (2024-04-04) | 288.35% |
| 1 year (2023-10-04) | 49.49% |
|---|---|
| 2 years (2022-10-04) | 221.74% |
| 3 years (2021-10-04) | 2.1 |
| 5 years (2019-10-04) | 1.53 |
| Revenue TTM | $9 million |
|---|---|
| Gross profit TTM | $4.8 million |
| Return on assets TTM | -79.49% |
| Return on equity TTM | -987.45% |
| Profit margin | -232.24% |
| Book value | $-13.26 |
| Market Capitalization | $2.2 million |
TTM: trailing 12 months
We're not expecting Nuwellis to pay a dividend over the next 12 months.
Nuwellis's shares were split on a 1:35 basis on 27 June 2024. So if you had owned 35 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Nuwellis shares – just the quantity. However, indirectly, the new 3400% higher share price could have impacted the market appetite for Nuwellis shares which in turn could have impacted Nuwellis's share price.
Over the last 12 months, Nuwellis's shares have ranged in value from as little as $1 up to $49.175. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Nuwellis's is 0.425. This would suggest that Nuwellis's shares are less volatile than average (for this exchange).
Nuwellis, Inc. , a medical device company, develops, manufactures, and commercializes medical devices used in ultrafiltration therapy. The company offers Aquadex FlexFlow and Aquadex SmartFlow systems, which are used to treat patients suffering from fluid overload due to heart failure. Its Aquadex FlexFlow system includes a console, disposable blood circuit set, and disposable catheter. The company sells its products to hospitals and clinics through its direct salesforce in the United States; and through independent specialty distributors in Austria, Belarus, Brazil, Colombia, the Czech Republic, Germany, Greece, Hong Kong, India, Israel, Italy, Panama, Romania, Singapore, Slovakia, Spain, Switzerland, Thailand, the United Arab Emirates, and the United Kingdom. The company was formerly known as CHF Solutions, Inc. and changed its name to Nuwellis, Inc.
Check out our picks of the best paper trading platforms to practice trading and investing with fake money.
These are the best day trading platforms, according to Finder’s comprehensive analysis.
Explore the best bonuses for opening a new brokerage account.
These are the best trading platforms for beginners, according to Finder’s comprehensive analysis.
Want to buy and sell international stocks? Here are the top brokers to help you trade global markets.
These are the best discount brokers of 2024 according to Finder’s comprehensive review.
Compare the 5 best stock picking services, according to Finder’s analysis, and learn how to choose the best option for your needs.
Check out our picks of the best trading apps for beginners, options traders, hands-off investors and more.
We’ve rounded up stats on some of the most popular graphene stocks, along with information on how they compare and how to invest.
Check out the best-performing ETFs so far in 2024.